Alopecia Areata

Baricitinib was effective in treating alopecia areata in two major trials.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Alopecia areata treatment varies, with no optimal method established yet.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Nail problems are common in people with alopecia areata, often leading to cosmetic and functional issues, but more research is needed for treatment guidelines.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Superficial cryotherapy significantly improves eyebrow hair growth in alopecia universalis patients.